Puxun Tian

Puxun Tian


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2018 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
Chenguang DingChenguang Ding
Chenguang Ding
FHFeng Han
Feng Han
HXHeli Xiang
Heli Xiang
YWYuxiang Wang
Yuxiang Wang
YLYang Li
Yang Li
PTPuxun Tian
Puxun Tian

4 December 2009 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
HYHang Yan
Hang Yan
CDChen-Guang Ding
Chen-Guang Ding
PTPuxun Tian
Puxun Tian
GGGuan-Qun Ge
Guan-Qun Ge
ZJZhan-Kui Jin
Zhan-Kui Jin
WXWu-Jun Xue
Wu-Jun Xue
In this paper we compared the two methods of cell sorting (magnetic cell sorting and flow cytometry sorting) for the isolation and function analysis of mouse CD4+ CD25+ regulatory T (Treg) cells, in order to inform further studies in Treg cell function. We separately used magnetic cell sorting and flow cytometry sorting to identify CD4+ CD25+ Treg cells. After magnetic cell separation, we further used flow cytometry to analyze the purity of CD4+ CD25+ Treg cells, trypan blue staining to detect cell viability, and propidium iodide (PI) staining to assess the cell viability. We detected the immune inhibition of CD4+ CD25+ Treg cells in the in vitro proliferation experiments. The results showed that compared to flow cytometry sorting, magnetic cell sorting took more time and effort, but fewer live cells were obtained than with flow cytometry sorting. The CD4+ CD25+ Treg cells, however, obtained with both methods have similar immunosuppressive capacities. The result suggests that both methods can be used in isolating CD4+ CD25+ Treg cells, and one can select the best method according to specific needs and availability of the methodologies.

14 July 2022 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
QWQianqian Wu
Qianqian Wu
XTXiaohui Tian
Xiaohui Tian
NGNianqiao Gong
Nianqiao Gong
JZJin Zheng
Jin Zheng
DLDandan Liang
Dandan Liang
JWJiqiu Wen
Jiqiu Wen
Background: Recently, early graft loss has become very rare in living-related kidney transplantation (LKT) as a result of decreased risk of hyperacute rejection and improvements in immunosuppressive regimens. Post-transplant acute thrombotic microangiopathy (TMA) is a rare, multi-factorial disease that often occurs shortly after kidney transplantation and is usually resistant to treatment with dismal renal outcomes. The complement genetic variants may accelerate the development of TMA. However, the complement genetic test was seldom performed in unknown native kidney disease recipients scheduled for LKT. Case presentation: We reported three cases of unknown native kidney diseases who had fulminant TMA in the allograft shortly after LKT. Both the donors and the recipients were noted to carry complement genetic variants, which were identified by genetic testing after transplantation. However, all recipients were refractory to treatment and had allograft loss within 3 months after LKT. Conclusion: This case series highlights the suggestion to screen complement gene variants in both the donors and the recipients with unknown native kidney diseases scheduled for LKT.

1 August 2017
Verified
Journal Article
Closed access
ZJZhankui Jin
Zhankui Jin
CXCuixiang Xu
Cuixiang Xu
WDWanli Duan
Wanli Duan
JYJiangcun Yang
Jiangcun Yang
PTPuxun Tian
Puxun Tian

1 January 2023 in Open Chemistry
Verified
Journal Article
Open access
PDF file
CLCheng Li
Cheng Li
HJHongli Jiang
Hongli Jiang
JYJingchun Yao
Jingchun Yao
XCXulong Chen
Xulong Chen
PTPuxun Tian
Puxun Tian
Radix puerariae has become the most commonly used medicine for diabetic nephropathy (DN). However, the mechanism of Radix puerariae in the treatment of DN is not completely clear. This study is to determine the active ingredients, targets, and signaling pathways of Radix puerariae for the treatment of DN using network pharmacology analysis and animal experiments to confirm its possible mechanism of action. A total of 12 potential effective components and 10 key therapeutic targets were obtained. The Kyoto Encyclopedia of Genes and Genomes enrichment analysis indicated that the use of Radix puerariae in DN treatment mainly involves HIF-1 signaling pathway, TNF signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, FoxO signaling, and VEGF signaling pathway. Molecular docking proved that the combined activity of the components with potential key targets were excellent. Animal experiments showed that Radix puerariae could improve the renal pathological structure in DN rats. Radix puerariae could decrease the content of AKT1, IL-6, INS, and reduce the expression levels of p-Akt/Akt and p-FoxO1/FoxO1 in renal tissue of DN rats. This study provides insight into the therapeutic potential and molecular mechanisms of Radix puerariae for treating DN.

1 July 2017
Verified
Journal Article
Closed access
ZJZhankui Jin
Zhankui Jin
CXCuixiang Xu
Cuixiang Xu
WDWanli Duan
Wanli Duan
JYJiangcun Yang
Jiangcun Yang
PTPuxun Tian
Puxun Tian